Delaware Statutes
§ 4902 — Sale or distribution of laetrile; labeling requirement
Laetrile (amygdalin, Vitamin B-17) may be distributed or sold by any person, and no special license or prescription shall be required for the sale or distribution of such substance. The label or other device affixed to a container containing laetrile (amygdalin, Vitamin B-17) shall include a statement that such substance has not yet been approved as a treatment or cure for cancer by the Food and Drug Administration of the United States Department of Health, Education and Welfare.
Free access — add to your briefcase to read the full text and ask questions with AI
Delaware § 4902 (Sale or distribution of laetrile; labeling requirement) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
61 Del. Laws, c. 90, § 2